Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,478,528 papers from all fields of science
Search
Sign In
Create Free Account
Leukemia, Myeloid, Accelerated Phase
Known as:
Aggressive-Phase Chronic Myeloid Leukemia
, Myeloid Leukemia, Chronic, Aggressive-Phase
, myelocytic leukemia, accelerated phase chronic
Expand
A phase of chronic myelogenous leukemia characterized by one or more of the following: 1) Myeloblasts accounting for 10-19% of the peripheral blood…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
30 relations
ABL1 gene
Anemia
BCR-ABL Fusion Gene
Bone Marrow
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting.
K. Tsukasaki
,
O. Hermine
,
+11 authors
Toshiki Watanabe
Journal of Clinical Oncology
2009
Corpus ID: 22671208
Adult T-cell leukemia-lymphoma (ATL) is a distinct peripheral T-lymphocytic malignancy associated with a retrovirus designated…
Expand
Review
2007
Review
2007
Chronic myeloid leukaemia
R. Hehlmann
,
A. Hochhaus
,
M. Baccarani
The Lancet
2007
Corpus ID: 1420863
Highly Cited
2007
Highly Cited
2007
Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase.
F. Guilhot
,
J. Apperley
,
+14 authors
M. Talpaz
Blood
2007
Corpus ID: 14700030
Treatment options are limited for patients with imatinib-resistant or -intolerant accelerated phase chronic myeloid leukemia (CML…
Expand
Highly Cited
2004
Highly Cited
2004
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.
M. Pfreundschuh
,
L. Trümper
,
+10 authors
M. Loeffler
Blood
2004
Corpus ID: 6515270
Cyclophosphamide, doxorubicin, vincristine, and prednisone, given every 3 weeks (CHOP-21), is standard chemotherapy for…
Expand
Highly Cited
2004
Highly Cited
2004
Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial.
H. Xiong
,
A. Rosenberg
,
+5 authors
J. Abbruzzese
Journal of Clinical Oncology
2004
Corpus ID: 42539846
PURPOSE To determine the response rate, time to disease progression, survival duration and rate, and toxicity with the…
Expand
Highly Cited
2004
Highly Cited
2004
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL…
M. Pfreundschuh
,
L. Trümper
,
+11 authors
M. Loeffler
Blood
2004
Corpus ID: 4647693
The combination of cyclophosphamide, doxorubicin, vincristine, and prednisone, given every 3 weeks (CHOP-21) is standard…
Expand
Highly Cited
2002
Highly Cited
2002
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study.
M. Talpaz
,
R. Silver
,
+19 authors
C. Sawyers
Blood
2002
Corpus ID: 29480569
Chronic myelogenous leukemia (CML) is caused by expression of the BCR-ABL tyrosine kinase oncogene, the product of the t(9;22…
Expand
Highly Cited
2001
Highly Cited
2001
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
V. Rusch
,
K. Rosenzweig
,
+6 authors
R. Ginsberg
Journal of Thoracic and Cardiovascular Surgery
2001
Corpus ID: 37869973
BACKGROUND Surgical resection of malignant pleural mesothelioma is reported to have up to an 80% rate of local recurrence. We…
Expand
Highly Cited
1997
Highly Cited
1997
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized…
J. Horiot
,
P. Bontemps
,
+10 authors
L. Collette
Radiotherapy and Oncology
1997
Corpus ID: 40694538
Highly Cited
1987
Highly Cited
1987
Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia
M. Gordon
,
C. Dowding
,
G. Riley
,
J. Goldman
,
M. Greaves
Nature
1987
Corpus ID: 4236877
Normal haematopoietic cell regulation involves interaction between marrow stromal cells and haematopoietic progenitor cells1…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE